Novo Nordisk Cuts Cash-Pay Price of Ozempic to $499/Month

Novo Nordisk has slashed the cash-pay price of its Type 2 diabetes medication Ozempic to around $499 per month, for uninsured customers.

Transcript

00:00Novo Nordisk has slashed the cash pay price of its type 2 diabetes medication Ozempic to around

00:05$500 a month, approximately half of its U.S. list price for self-paying uninsured patients.

00:13The discounted offer is available directly through Novo's NovoCare Pharmacy with home

00:18delivery and via the drug savings platform GoodRx. The move mirrors a similar reduction

00:24for Ozempic's weight loss counterpart WegoV, signaling the company's broader push toward

00:29direct-to-consumer access amid pressure to lower drug costs. The announcement also helped to lift

00:35investor optimism on the day, boosting Novo Nordisk shares following heightened focus on

00:40pharma pricing strategies.